| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 0 |
| Total Expenses - EUR | - | 2.479 | 1.444 | 1.340 | 3.343 | 6.833 | 6.239 | 6.705 | 6.226 | 2.428 |
| Gross Profit/Loss - EUR | - | -2.479 | -1.444 | -1.340 | -3.343 | -6.833 | -6.239 | -6.705 | -6.211 | -2.428 |
| Net Profit/Loss - EUR | - | -2.479 | -1.444 | -1.340 | -3.343 | -6.833 | -6.239 | -6.705 | -6.211 | -2.428 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
Check the financial reports for the company - Vivtens Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 13 | 13 | 13 | 13.811 | 41.739 | 35.847 | 30.976 | 26.197 | 24.473 |
| Current Assets | - | 22 | 14 | 24 | 105 | 0 | 1 | 2 | 1.610 | 1.239 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | 22 | 14 | 24 | 105 | 0 | 1 | 2 | 1.610 | 1.239 |
| Shareholders Funds | - | -2.434 | -3.837 | -5.106 | -8.378 | -15.051 | -20.957 | -27.726 | -33.853 | -36.092 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.469 | 3.864 | 5.143 | 22.293 | 56.790 | 56.804 | 58.704 | 61.660 | 61.804 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Vivtens Med Srl